151 related articles for article (PubMed ID: 32039532)
1. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
[TBL] [Abstract][Full Text] [Related]
2. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
Pak MG; Shin DH; Lee CH; Lee MK
World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
[TBL] [Abstract][Full Text] [Related]
3. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
Li Z; Jiang X; Zhang W
Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
[TBL] [Abstract][Full Text] [Related]
4. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway.
Guo X; Zhu X; Zhao L; Li X; Cheng D; Feng K
Tumour Biol; 2017 Mar; 39(3):1010428317694324. PubMed ID: 28345466
[TBL] [Abstract][Full Text] [Related]
6. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
[TBL] [Abstract][Full Text] [Related]
7. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
8. Variation of Trop2 on non-small-cell lung cancer and normal cell membranes revealed by super-resolution fluorescence imaging.
Fu Y; Jing Y; Gao J; Li Z; Wang H; Cai M; Tong T
Talanta; 2020 Jan; 207():120312. PubMed ID: 31594569
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
[TBL] [Abstract][Full Text] [Related]
10. The Rise of the TROP2-Targeting Agents in NSCLC: New Options on the Horizon.
Ahmed Y; Berenguer-Pina JJ; Mahgoub T
Oncology; 2021; 99(10):673-680. PubMed ID: 34280931
[TBL] [Abstract][Full Text] [Related]
11. Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer.
Jeon Y; Jo U; Hong J; Gong G; Lee HJ
BMC Cancer; 2022 Sep; 22(1):1014. PubMed ID: 36153494
[TBL] [Abstract][Full Text] [Related]
12. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
Lin JC; Wu YY; Wu JY; Lin TC; Wu CT; Chang YL; Jou YS; Hong TM; Yang PC
EMBO Mol Med; 2012 Jun; 4(6):472-85. PubMed ID: 22419550
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.
Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB
Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
15. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
16. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma.
Nakashima K; Shimada H; Ochiai T; Kuboshima M; Kuroiwa N; Okazumi S; Matsubara H; Nomura F; Takiguchi M; Hiwasa T
Int J Cancer; 2004 Dec; 112(6):1029-35. PubMed ID: 15386348
[TBL] [Abstract][Full Text] [Related]
17. Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
Bahlinger V; Branz A; Strissel PL; Strick R; Lange F; Geppert CI; Klümper N; Hölzel M; Wach S; Taubert H; Sikic D; Wullich B; Angeloni M; Ferrazzi F; Diehl L; Kovalenko M; Elboudwarej E; Jürgensmeier JM; Hartmann A; Eckstein M
Histopathology; 2024 Apr; 84(5):863-876. PubMed ID: 38196202
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
19. Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?
Akarken İ; Dere Y
Ann Diagn Pathol; 2021 Feb; 50():151680. PubMed ID: 33341704
[TBL] [Abstract][Full Text] [Related]
20. Targeting Trop2 in solid tumors: a look into structures and novel epitopes.
Liu X; Li J; Deng J; Zhao J; Zhao G; Zhang T; Jiang H; Liang B; Xing D; Wang J
Front Immunol; 2023; 14():1332489. PubMed ID: 38179054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
